Compound information
- Natural Products
- ZC4337
- Molecular Formula
- C11H15N3O5
- Molecular Weight
- 269.10117058 g/mol
- Structure
-
- IUPAC Name
- 1,4-bis[[(2R)-oxiran-2-yl]methyl]-2-[[(2S)-oxiran-2-yl]methyl]-1,2,4-triazolidine-3,5-dione
- InChI
- InChI=1S/C11H15N3O5/c15-10-12(1-7-4-17-7)11(16)14(3-9-6-19-9)13(10)2-8-5-18-8/h7-9H,1-6H2/t7-,8-,9+/m1/s1
- InChI Key
- ZTXDHEQQZVFGPK-HLTSFMKQSA-N
- SMILES
- O=c1n(C[C@@H]2CO2)c(=O)n(C[C@@H]2CO2)n1C[C@H]1CO1
- Source
- ZINC000072266900
Warheads
- Epoxide
-
- Epoxide
-
- Epoxide
-
ADMET Property
Physicochemical Property
| Property | Value | Property | Value |
|---|---|---|---|
| Heavy Atom Count | 19 | Ring Count | 4 |
| Heteroatom Count | 8 | Rotatable Bond Count | 6 |
| Hydrogen Bond Acceptor Count | 8 | Hydrogen Bond Donor Count | 0 |
| Topological Polar Surface Area | 86.52 Å2 | LogP | -0.563 |
| LogS | -1.333 | LogD | 0.065 |
Absorption
| Property | Value | Property | Value |
|---|---|---|---|
| Pgp inhibitor | 0.691 | Pgp substrate | 0.152 |
| HIA | 0.908 | F20 % | 0.866 |
| F30 % | 0.373 | Caco-2 | -4.312 |
| MDCK | -5.039 |
Distribution
| Property | Value | Property | Value |
|---|---|---|---|
| BBB Penetration | 0.99 | PPB | 70.627 |
| VD | 0.776 | Fu | 0.093 |
Metabolism
| Property | Value | Property | Value |
|---|---|---|---|
| CYP1A2 inhibitor | 0.032 | CYP1A2 substrate | 0.592 |
| CYP2A6 substrate | 0.637 | CYP2B6 substrate | 0.435 |
| CYP2C19 inhibitor | 0.039 | CYP2C19 substrate | 0.569 |
| CYP2C8 substrate | 0.54 | CYP2C9 inhibitor | 0.011 |
| CYP2C9 substrate | 0.622 | CYP2D6 inhibitor | 0.02 |
| CYP2D6 substrate | 0.539 | CYP2E1 substrate | 0.266 |
| CYP3A4 inhibitor | 0.937 | CYP3A4 substrate | 0.998 |
Excretion
| Property | Value | Property | Value |
|---|---|---|---|
| T1/2 | 0.936 | CL | 1.448 |
Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| hERG Blockers | 0.112 | Hepatotoxicity | 0.985 |
| Mutagenicity | 0.998 | Rat Oral Acute Toxicity | 0.895 |
| FDAMDD | 0.191 | Skin Sensitization | 0.289 |
| Carcinogenicity | 0.963 | Eye Corrosion | 0.058 |
| Eye Irritation | 0.781 | Respiratory Toxicity | 0.169 |
Environmental Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| Bioconcentration Factors | 0.212 | IGC50 | 2.474 |
| LC50FM | -0.257 | LC50DM | -0.083 |
Tox21 Pathway
| Property | Value | Property | Value |
|---|---|---|---|
| NR-AR | 0.223 | NR-AR-LBD | 0.326 |
| NR-AhR | 0.004 | NR-Aromatase | 0.029 |
| NR-ER | 0.088 | NR-ER-LBD | 0.331 |
| NR-PPAR-gamma | 0.114 | SR-ARE | 0.082 |
| SR-ATAD5 | 0.656 | SR-HSE | 0.819 |
| SR-MMP | 0.007 | SR-p53 | 0.8 |
Similar covalent drugs
No similar covalent drugs found for this compound.